Practices increasingly need to use technology to deliver care in an increasingly value-based world, said Charles Saunders, MD, CEO of Integra Connect.
Practices increasingly need to use technology to deliver care in an increasingly value-based world, said Charles Saunders, MD, CEO of Integra Connect.
Transcript
Technology is increasingly important in delivery care—how are cancer practices benefiting from integrating technology into their practice?
Well, there are several elements of technology that are necessary in today’s post-MACRA [Medicare Access and CHIP Reauthorization Act], value-based world. The first of all is an electronic health record, which is a requirement of the Oncology Care Model. The second is technology to integrate data from a wide variety of sources, and to perform analysis of that data. Not only to measure either MIPS [Merit-based Incentive Payment System] or alternative payment model quality measures, but also to understand the drivers of cost and where there are opportunities to be more efficient and to save.
In addition, practices that are in the Oncology Care Model need to manage patients in between office visits to make sure that they avoid unnecessary emergency department visits, hospitalizations, and they engage in end-of-life, palliative care, and hospice care. So, having a care management platform and technology and to engage with patients is essential. And in cases where they are connecting clinical trials, they also need to have the ability to manage those trials and that generally means some type of clinical trials management system or ability to capture patient-entered data.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More